PATENT CLAIM ANALYSIS

Application Number: 15902537
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["546", "015000"]

Abstract:
This invention relates to compounds that are agonists of the muscarinic M1 receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula 1, or a salt thereof, wherein Q, R 1 , R 2 , R 3  and R 4  are as defined herein.

Claim (Index 32):
The compound according to  claim 27  wherein the moiety: is selected from groups AAA to ACB and CAA to CBZ:

Metadata:
- Claim Count in Document: 68.0
- Percentile: 88.0
- Lexical Diversity: 1.52941
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15591605', '15117018', '15595107', '14996829', '14428927']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8720945733260478
- 35 USC 102 Novelty (BERT): 0.6004352774982027
- Combined Prediction Score: 0.8449286437432633
- Mean Citation Score: 556.90546
- Max Citation Score: 640.4448
- Similarity Product: 448.110598008728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test